Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries

While a substantial amount of evidence exists on factors associated with positive health technology assessment (HTA) outcomes, the evidence on the same regarding rejections is scarce. Using a proprietary dataset of HTA outcomes in seven Organisation for Economic Co-operation and Development (OECD) c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Filippos Papadopoulos, Erica Visintin, Ilias Kyriopoulos, Panos Kanavos
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Cambridge University Press 2025-07-01
coleção:	Health Economics, Policy and Law
Assuntos:	Health technology assessment pharmaceutical reimbursement priority setting resource allocation coverage decisions
Acesso em linha:	https://www.cambridge.org/core/product/identifier/S1744133125100212/type/journal_article
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!